Lonza Biologics

lonza.com · Manchester, United States of America

Lonza Biologics is a division of Lonza Group that provides contract development and manufacturing services for biologic drugs, including monoclonal antibodies, recombinant proteins, cell and gene therapies, and other complex biologics for pharmaceutical and biotechnology companies. It offers process development, clinical and commercial-scale manufacturing, and related regulatory and analytical services on a fee-for-service and long-term supply agreement basis. The business generates revenue through outsourced biopharmaceutical manufacturing and development contracts with global life sciences customers.

Revenue
$1B+
Employees
5,001+
Founded
1996
Headquarters
Manchester, United States of America

Lonza Biologics customers on Arbolus

Total customers 8 7 current · 1 former
Reviews growth 8 new reviews since Feb 2026

Customers who reviewed Lonza Biologics

Seniority of Lonza Biologics customers

Most people who reviewed Lonza Biologics hold Director roles (75%), followed by C-Suite (25%).

  • Director 75%
  • C-Suite 25%

Customers sample

Revenue Leader Director NPS 8 Will renew
Operations Leader Director NPS 8 Will renew
Executive C-Suite NPS 8 Will renew

Employer names and spend open once the report publishes.

What 8 Arbolus experts think of Lonza Biologics

Overall sentiment: Positive

The NPS score distribution is strong, with two scores of 10, three scores of 9, and multiple 8s, averaging 8.75. Six out of seven experts providing renewal intent indicated they plan to renew, while one large account is unsure. Stickiness is high, with 87.5% reporting more than one year of use or greater adoption. Key themes: high satisfaction, strong engagement from large enterprise buyers, and some renewal risk concentrated in high-value accounts.

Tell us when the Lonza Biologics report publishes.

We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.

Sentiment

37 Net Promoter Score, from 8 scored reviews
  • Promoters 3
  • Passives 5
  • Detractors 0

Written answers and themes publish with the full report.

Renewal intent

Plan to renew 100%
  • Will renew 5
  • Undecided 0
  • Not renewing 0

Plan to renew, by seniority

  • C-Suite 100% 1 answer
  • Director 100% 4 answers
  • 8.4/10 Average score from customers who will renew

For people who use Lonza Biologics

Do you use Lonza Biologics at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 8 customers of Lonza Biologics have already contributed

Takes a few minutes. Your identity stays anonymous.